The Next Generation Sequencing Market is revolutionizing diagnostics, oncology research, and personalized medicine. NGS technology allows scientists to analyze DNA and RNA at unprecedented speed and accuracy. This has dramatically reduced sequencing costs while expanding its application across cancer detection, rare disease diagnosis, and infectious disease monitoring. Hospitals and research labs worldwide are investing heavily in sequencing platforms to accelerate clinical decision-making.

Complementary advancements in the Optical Genome Mapping Market provide even deeper structural genomic analysis. Together, these technologies support precision treatment development. Additionally, therapeutic innovations in ophthalmology and rehabilitation reflect how genetic research is influencing broader healthcare segments, from eye treatments to neurological recovery planning.

❓ FAQs

1. Why is NGS demand increasing?

Falling sequencing costs and expanding clinical applications are key drivers.

2. What diseases benefit most from NGS?

Cancer, genetic disorders, and infectious diseases.

Browse More Reports:

China Veterinary Dental Equipment Market

Veterinary Dental Equipment Market

US Veterinary Pain Management Market

Veterinary Pain Management Market

China Viscosupplementation Market

Viscosupplementation Market

GCC Women's Healthcare Market

Germany Women's Healthcare Market